| Balance Sheets | 2025-06-30 | |||
|---|---|---|---|---|
| Property and equipment, net | 5,129 | |||
| Goodwill | 8,450 | |||
| Prepaid expenses and other current assets | 695 | |||
| Cash and cash equivalents | 4,402 | |||
| Accounts receivable, net of allowance of 664 and 390, respectively | 1,633 | |||
| Total current assets | 6,730 | |||
| Operating lease right-of-use asset | 3,244 | |||
| Intangible assets, net | 2,225 | |||
| Deposits and other | 255 | |||
| Total assets | 26,033 | |||
| Accrued expenses | 2,302 | |||
| Other current liabilities | 1,015 | |||
| Current portion of operating lease liability | 654 | |||
| Current portion of debt | 157 | |||
| Current portion of financing lease liability | 55 | |||
| Current portion of contract liabilities | 480 | |||
| Accounts payable | 1,763 | |||
| Total current liabilities | 6,426 | |||
| Other liabilities | 1,400 | |||
| Operating lease liability, net of current portion | 2,814 | |||
| Debt, net of current portion | 7,760 | |||
| Financing lease liability, net of current portion | 141 | |||
| Contract liabilities, net of current portion | 5 | |||
| Employee retention credit liability | 2,904 | |||
| Total liabilities | 21,450 | |||
| Accumulated deficit | -113,064 | |||
| Additional paid-in capital | 117,647 | |||
| Total stockholders equity | 4,583 | |||
| Total liabilities and stockholders equity | 26,033 | |||
Vivos Therapeutics, Inc. (VVOS)
Vivos Therapeutics, Inc. (VVOS)